| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 115 |
| 1 | METHOTREXATE | 106 |
| 2 | BEVACIZUMAB | 96 |
| 3 | CYCLOPHOSPHAMIDE | 90 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 90 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 90 |
| 6 | CYTARABINE | 73 |
| 7 | MERCAPTOPURINE | 66 |
| 8 | TEMOZOLOMIDE | 56 |
| 9 | TRAMETINIB | 49 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | THIOGUANINE | 28 | 0.0132 |
| 1 | LAROTRECTINIB | 7 | 0.0078 |
| 2 | SELUMETINIB | 9 | 0.0053 |
| 3 | MERCAPTOPURINE | 66 | 0.0038 |
| 4 | ADALIMUMAB-AACF | 1 | 0.0030 |
| 5 | TEMOZOLOMIDE | 56 | 0.0026 |
| 6 | LOMUSTINE | 6 | 0.0023 |
| 7 | TRAMETINIB | 49 | 0.0020 |
| 8 | NIVOLUMAB AND RELATLIMAB-RMBW | 1 | 0.0019 |
| 9 | DAUNORUBICIN HYDROCHLORIDE | 3 | 0.0018 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 157 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 106 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 100 |
| 3 | Corticosteroid [EPC] | 84 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 73 |
| 5 | Platinum-based Drug [EPC] | 51 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 48 |
| 7 | Kinase Inhibitor [EPC] | 27 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 26 |
| 9 | Topoisomerase Inhibitor [EPC] | 23 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 1 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 4 | 0.0018 |
| 2 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |
| 3 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 4 | Leptin Analog [EPC] | 1 | 0.0008 |
| 5 | Alkylating Drug [EPC] | 157 | 0.0006 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 100 | 0.0005 |
| 7 | Recombinant Human Growth Hormone [EPC] | 10 | 0.0005 |
| 8 | Selective T Cell Costimulation Blocker [EPC] | 2 | 0.0004 |
| 9 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |